NGS analyses revealed that the CN of BRCA2 and RB1 in adjacent normal prostate tissues was not decreased in 10 patients with PC with tumor BRCA2 alteration (Table 3), suggesting that in the present study, BRCA2 and/or RB1 deletions were caused by somatic gene alterations. The gene discussed is BRCA2; the disease is neoplasm.